Instituto Rosenbusch

Instituto Rosenbusch EBIT CAGR 5Y

EBIT CAGR (5 Year) of Instituto Rosenbusch (ROSE2.BA) as of Oct 17, 2026.

EBIT CAGR 5Y

-

Last updated:

EBIT CAGR (5 Year) of Instituto Rosenbusch is 2026 - . EBIT CAGR (5 Year) of Instituto Rosenbusch was 2025 42.92 % . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Instituto Rosenbusch Stock analysis

What does Instituto Rosenbusch do? Instituto Rosenbusch SA, based in Buenos Aires, Argentina, operates in the Health Care sector, specifically in Pharmaceuticals. The company manufactures and markets veterinary products, including pharmaceuticals such as antibiotics, antimastitics, antimycotics, antiparasites, vitamins, and minerals, as well as biological products like vaccines for cattle, equines, pigs, sheep, and dogs. It also engages in meat slaughtering and provision. Listed on 21 February 2008, the company owns subsidiaries including Laboratorios Rosenbusch SA, Laboratorios Bolivar SA, and Rosenbusch Paraguay SA. Instituto Rosenbusch is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Instituto Rosenbusch stock

On Eulerpool you can find the complete historical development of EBIT CAGR (5 Year) Instituto Rosenbusch since 2006 – with annual values, charts, and detailed analysis.

The 5-year EBIT CAGR shows the compound annual growth rate of EBIT over the past five years.

To evaluate EBIT CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT CAGR (5 Year).

EBIT CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT CAGR (5 Year)'s Instituto Rosenbusch historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Growth — Instituto Rosenbusch

Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth

All Key Metrics — Instituto Rosenbusch